Chronic Spontaneous Urticaria Clinical and Nonclinical Studies, Key Companies, Treatment Evaluation, Emerging Therapies, Treatment Algorithms, Pipeline Analysis | United BioPharma, Teva Pharmaceuticals Development, Inc., Amgen, Novartis Pharmaceuticals
Pipeline insights for chronic spontaneous urticaria, DelveInsight
According to DelveInsight analysis, the chronic spontaneous urticaria (CSU) pipeline consists of more than 20 leading companies actively developing more than 20 treatments for CSU.
Overview of Chronic Spontaneous Urticaria:
Urticaria, commonly known as hives, wheals, or nettle rash, is characterized by itchy, red,...
0 Comments
0 Shares
French
Dutch